These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1259596)

  • 1. Efficacy and immune response to rubella subunits vaccines.
    Cappel R; De Cuyper F
    Arch Virol; 1976; 50(3):207-13. PubMed ID: 1259596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell mediated immunity in experimental rubella infections.
    Cappel R
    Arch Virol; 1975; 47(4):375-9. PubMed ID: 1137503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Present status of vaccines for rubella.
    Sever JL
    Arch Otolaryngol; 1973 Oct; 98(4):265-8. PubMed ID: 4205025
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetic stability in humans of the rabbit immunogenic marker of Cendehill rubella vaccine virus.
    Gill SD; Furesz J
    Arch Gesamte Virusforsch; 1973; 43(1):135-43. PubMed ID: 4793528
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of possible transplacental infection with rubella vaccination during pregnancy.
    Bolognese RJ; Corson SL; Fuccillo DA; Sever JL; Traub R
    Am J Obstet Gynecol; 1973 Dec; 117(7):939-41. PubMed ID: 4759831
    [No Abstract]   [Full Text] [Related]  

  • 6. Serological survey for rubella and measles antibodies among first graders.
    Schiff GM; Linnemann CC; Shea L; Witte JJ; Ackerman JH; Stapleton L; Elsea WR; Agna M
    JAMA; 1974 Jan; 227(1):49-52. PubMed ID: 4859626
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of immunization against rubella on lactation products. I. Development and characterization of specific immunologic reactivity in breast milk.
    Losonsky GA; Fishaut JM; Strussenberg J; Ogra PL
    J Infect Dis; 1982 May; 145(5):654-60. PubMed ID: 7077089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of cell-mediated immunity to rubella virus 5 years after rubella vaccination.
    Rossier E; Phipps PH; Polley JR; Webb T
    Can Med Assoc J; 1977 Mar; 116(5):481-4. PubMed ID: 837312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination by non-parenteral routes: characteristics of immune response.
    Ogra PL; Chiba Y; Beutner KR; Morag A
    Dev Biol Stand; 1976; 33():19-26. PubMed ID: 782968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are many women immunized against rubella unnecessarily?
    Mortimer PP; Edwards JM; Porter AD; Tedder RS; Mace JE; Hutchinson A
    J Hyg (Lond); 1981 Aug; 87(1):131-8. PubMed ID: 7019319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rubella screening in school girls using the radial hemolysis test and their vaccination with attenuated live vaccine of the RA23/3 strain].
    Strauss J; Benes C; Macátová I
    Z Gesamte Hyg; 1988 Oct; 34(10):589-91. PubMed ID: 3201803
    [No Abstract]   [Full Text] [Related]  

  • 12. Persistent rubella infection and rubella-associated arthritis.
    Chantler JK; Ford DK; Tingle AJ
    Lancet; 1982 Jun; 1(8285):1323-5. PubMed ID: 6123637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rubella screening and directed vaccination of 14-year-old girls with live rubella vaccine RA 27/3 in the Liberec district].
    Strauss J; Zikmundová V; Stovicek Z; Zikmund V; Téminová V; Langhammer O; Kokesová O
    Cesk Epidemiol Mikrobiol Imunol; 1982 Sep; 31(5):266-76. PubMed ID: 6215992
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of rubella vaccine on transplacental rubella virus infection in rabbits.
    Cohen SM; Deibel R; Collins DN; Schryver GD; Ducharme CP
    J Lab Clin Med; 1972 Aug; 80(2):179-89. PubMed ID: 4558011
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the reactogenicity and immunogenicity of the BRD-2 and RA27/3 live attenuated rubella vaccines.
    Wang SS; Han YR; Su WN; Chen J; Zhao K
    Vaccine; 1984 Dec; 2(4):277-80. PubMed ID: 6531968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postpartum immunization with rubella virus vaccine and antibody response in breast-feeding infants.
    Krogh V; Duffy LC; Wong D; Rosenband M; Riddlesberger KR; Ogra PL
    J Lab Clin Med; 1989 Jun; 113(6):695-9. PubMed ID: 2732617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro lymphocyte reactivity to rubella antigen following vaccination.
    Heigl Z; Wasserman J; Forsgren M
    Scand J Infect Dis; 1980; 12(1):13-20. PubMed ID: 6988953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late seroconversion following HPV-77, DE5 rubella virus vaccine.
    Wilkins J
    Am J Obstet Gynecol; 1975 Apr; 121(7):998-1002. PubMed ID: 1115189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of rubella virus E2 and C proteins in protection against rubella virus in a mouse model.
    Cusi MG; Valassina M; Bianchi S; Wunner W; Valensin PE
    Virus Res; 1995 Aug; 37(3):199-208. PubMed ID: 8533457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetomaternal apects of immunization with RA27/3 live attenuated rubella virus vaccine during pregnancy.
    Bernstein DI; Ogra PL
    J Pediatr; 1980 Sep; 97(3):467-70. PubMed ID: 7411312
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.